Image

Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development

Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development

Recruiting
40-85 years
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

Our study aimed to use an AF-predict AI-ECG alert system to help physicians identify patients who need to wear a continuous cardiac rhythm monitor for new diagnoses of atrial fibrillation (AF), atrial flutter (AFL), or atrial arrhythmia with high AF risk, including premature atrial complexes (PAC) ≥ 500/24hr, burst PACs \> 20 beats, non-sustained AF/AFL.

Eligibility

Inclusion Criteria:

  • Patients in the inpatient department or the outpatient department
  • Patients need to have at least one electrocardiogram within one year

Exclusion Criteria:

  • Diagnosis of atrial fibrillation/atrial flutter
  • History of atrial fibrillation/atrial flutter catheter ablation
  • Patients with cardiac implantable electronic devices
  • Any documented electrocardiogram showed atrial fibrillation/atrial flutter and pacing rhythm
  • History of received rhythm control medications for atrial arrhythmia, including Class I and Class III antiarrhythmic drugs
  • Any reasons indicate for anti-coagulant agents, including vitamin K antagonist and non-vitamin K antagonist oral anticoagulant

Study details
    Atrial Fibrillation (AF)
    Premature Atrial Complexes
    Atrial Arrhythmias
    Artificial Intelligence (AI)
    Electrocardiogram

NCT06847932

National Defense Medical Center, Taiwan

31 January 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.